MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
142.59%
Quick Ratio
134.37%
Cash Ratio
69.47%
Debt to Asset Ratio
89.06%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Inventories, net
    • Non-current inventory and other ...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
319,850
305,106
322,933
325,272
Accounts receivable, net
277,459
251,062
224,464
196,507
Inventories, net
37,883
31,515
27,938
23,774
Prepaid and other current assets
21,377
23,523
13,651
19,789
Total current assets
656,569
611,206
588,986
565,342
Equipment, net
874
567
562
605
Right-of-use asset - operating lease
19,157
20,014
20,858
21,654
Goodwill
12,042
12,042
12,042
12,042
Intangible asset, net
37,358
38,947
40,519
42,126
Non-current inventory and other assets
35,447
30,831
26,838
27,481
Total assets
761,447
713,607
689,805
669,250
Accounts payable
78,969
106,702
65,537
54,227
Accrued expenses and other current liabilities
299,632
250,731
232,853
225,632
Operating lease liability, current portion
646
628
434
736
Contingent consideration, current
11,199
11,150
10,012
9,695
Short-term borrowings
70,000
70,000
70,000
70,000
Total current liabilities
460,446
439,211
378,836
360,290
Contingent consideration, non-current
69,135
73,730
77,540
89,870
Loan payable, long-term
117,958
117,850
117,746
117,642
Operating lease liability, long-term
21,574
22,385
23,182
23,041
Finance lease liability, long-term
9,030
5,844
4,206
4,680
Total liabilities
678,143
659,020
601,510
595,523
Common stock, 0.0001 par value per share (150,000,000 shares authorized, 52,299,889 and 50,882,766 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively)
5
5
5
5
Additional paid-in capital
1,505,116
1,425,085
1,394,251
1,351,124
Accumulated deficit
-1,421,817
-1,370,503
-1,305,961
-1,277,402
Total stockholders equity
83,304
54,587
88,295
73,727
Total liabilities and stockholders equity
761,447
713,607
689,805
669,250
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$319,850K (5.56%↑ Y/Y)Accounts receivable, net$277,459K (39.55%↑ Y/Y)Inventories, net$37,883K (105.43%↑ Y/Y)Prepaid and othercurrent assets$21,377K (30.84%↑ Y/Y)Total current assets$656,569K (22.35%↑ Y/Y)Intangible asset, net$37,358K (-14.58%↓ Y/Y)Non-current inventory andother assets$35,447K (46.17%↑ Y/Y)Right-of-use asset -operating lease$19,157K (-14.75%↓ Y/Y)Goodwill$12,042K (0.00%↑ Y/Y)Equipment, net$874K (31.03%↑ Y/Y)Total assets$761,447K (19.02%↑ Y/Y)Total liabilities andstockholders equity$761,447K (19.02%↑ Y/Y)Total liabilities$678,143K (19.66%↑ Y/Y)Total stockholdersequity$83,304K (14.00%↑ Y/Y)Accumulated deficit-$1,421,817K (-15.58%↓ Y/Y)Total currentliabilities$460,446K (34.59%↑ Y/Y)Loan payable,long-term$117,958K (0.36%↑ Y/Y)Contingent consideration,non-current$69,135K (-13.21%↓ Y/Y)Operating leaseliability, long-term$21,574K (-8.68%↓ Y/Y)Finance leaseliability, long-term$9,030K (138.13%↑ Y/Y)Additional paid-in capital$1,505,116K (15.49%↑ Y/Y)Common stock, 0.0001par value per share...$5K (0.00%↑ Y/Y)Accrued expenses andother current...$299,632K (75.32%↑ Y/Y)Accounts payable$78,969K (-13.82%↓ Y/Y)Short-term borrowings$70,000K (0.00%↑ Y/Y)Contingent consideration,current$11,199K (21.31%↑ Y/Y)Operating leaseliability, current portion$646K (91.69%↑ Y/Y)

Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM)